A Crucial Crossroads: Will the U.S. Remain Committed to Ending HIV/AIDS?
The global fight against HIV/AIDS has achieved remarkable progress over the past two decades. With substantial investments from the United States, millions living with HIV now access life-saving treatment, and new infections have declined significantly. However, as the world grapples with new challenges, preserving this hard-won progress hinges on a critical question: will the U.S. remain steadfast in its commitment to ending HIV/AIDS?
While the world celebrates milestones like the declining number of pediatric HIV cases and advancements in long-acting prevention technologies, a complex reality persists. Over one million new HIV diagnoses emerged globally in 2023, hitting women and girls hardest. Notably, adolescent girls and young women in sub-Saharan Africa literally bear half the burden of new infections among youth aged 15-24.
Adding to these complexities, the global landscape for fighting HIV is evolving. Pandemic fatigue stemming from the COVID-19 crisis, coupled with the shifting priorities of international donors, presents a formidable challenge. Traditional strongholds of funding secured by PEPFAR, the President’s Emergency Plan for AIDS Relief, face increasing competition. Domestic political shifts in the United States cast a shadow on bipartisan commitment to HIV/AIDS initiatives. "Rollbacks around reproductive rights, such as Uganda’s Anti-Homosexuality Act," experts note, "make it more difficult for individuals to access vital health services, further jeopardizing hard-fought advancements."
Despite these headwinds, there is still hope. The CSIS Bipartisan Alliance for Global Health Security, recognizing the intersection between HIV eradication and global health security, highlighted PEPFAR’s role in strengthening health systems and responding to outbreaks. The release of their initial report, "Centering PEPFAR in U.S. Global Health Security Strategies," called for the U.S. to prioritize HIV and improve coordination between PEPFAR and other healthcare initiatives. Their message is clear: bolstering investment in HIV not only saves lives from the devastating impact of the virus but also fortifies global public health security.
As the United States prepares for a new presidential administration and Congress in 2025, the debate surrounding HIV funding is at a crucial juncture. While the future of PEPFAR hangs in the balance, global health experts remain adamant:
Let there be no mistake – a decline in U.S. commitment to HIV will have tremendous consequences.
Several urgent steps must be taken to ensure the U.S. doesn’t ditch its progress, including:
- Prioritize PEPFAR Reauthorization:
"A vigorous campaign is needed to ensure a multi-year reauthorization of PEPFAR, reassuring Congress and the American people that PEPFAR is collaborating with implementing countries to chart a clear path towards program sustainability, with a vision of increasing domestic financing and reducing donor funding over time," the CSIS Alliance succinctly states.
While Congress reauthorized PEPFAR successfully in the past, "pandemic fresher" and shifts in political priorities raise serious concerns about its next iteration.
- Emphasize Equity:
Focusing on a multi-year strategy, the SIshadowColor PEPFAR:
"…PEPFAR’s work must prioritize reaching marginalized populations. New infections remain stubbornly high among key populations and young women. Addressing this requires a dedicated strategy for formative investment. For example, PEPFAR’s recent Action Plan, recently released, making accessing prevention and treatment a fundamental human right."
- Secure Global Health, Secure U.S. Interests:
The U.S. Department of State outlined a five-year plan emphasizing that investments in HIV are investments in global health security. As Americans tackle domestic challenges like COVID-19, PEPFAR initiatives act as an early warning system against future pandemics.
HIV is not just a global health issue; it is a security issue for the United States. The threats reprsent by emerging infecti olutions and trans inquiries.
The incoming administration has an opportunity to demonstrate strong leadership by embracing these crucial steps—and protecting a generation from suffering the pain of HIV/AIDS.
“With close to 40 million people currently living with HIV, the time to act is now. There are no easy answers, but the urgency can not be overstated,"
said one
,
